| Authors: |
Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.; INSIGNEO, University of Sheffield, Sheffield, UK., Doyle O; Real-World & Analytical Solutions, IQVIA, London, UK., Drage E; Real-World & Analytical Solutions, IQVIA, London, UK., Jenner H; Real-World & Analytical Solutions, IQVIA, London, UK., Salvatelli V; Real-World & Analytical Solutions, IQVIA, London, UK., Daniels FA; Real-World & Analytical Solutions, IQVIA, London, UK., Rigg J; Real-World & Analytical Solutions, IQVIA, London, UK., Schmitt C; GSK, Middlesex, UK., Samyshkin Y; GSK, Middlesex, UK., Lawrie A; Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.; INSIGNEO, University of Sheffield, Sheffield, UK., Bergemann R; Evalueserve UK Ltd, London, UK. |
